← back to search

Paolo Giorgi Rossi

Tecnologie Avanzate (Italy) · IT
Area of research
Oncology · Epidemiology
Research interest
Research interests include Global Cancer Incidence and Screening, Cervical Cancer and HPV Research, Colorectal Cancer Screening and Detection, and COVID-19 Clinical Research Studies.
h-index
65
citations
24,201
works
870
NIH funding
primary concept
email

Recent publications

Mid-term effects of faecal immunochemical test screening on colorectal cancer incidence by tumour site
Digestive and Liver Disease 2026cited by 0position: middledoi
Distinct viral reservoirs and immune signatures in individuals on long-term antiretroviral therapy with perinatally acquired HIV-1
Cell Reports Medicine 2025cited by 14position: middledoi
Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
British Journal of Cancer 2025cited by 5position: middledoi
Correction: Italian guidelines for cervical cancer screening. Multisocietal recommendations on the use of biomarkers in HPV screening with risk-based approach and GRADE methodology
British Journal of Cancer 2025cited by 0position: middledoi
Cholangiocarcinoma and Occupational Exposure to Asbestos: Insights From the Italian Pooled Cohort Study
˜La œMedicina del lavoro 2024cited by 0position: middledoi
A systematic review of the cost-effectiveness of interventions to increase cervical cancer screening among underserved women in Europe
The European Journal of Health Economics 2023cited by 7position: middledoi
Cause specific mortality in an Italian pool of asbestos workers cohorts
American Journal of Industrial Medicine 2023cited by 7position: middledoi
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial
BMC Cancer 2022cited by 100position: middledoi
Performance of <scp>HPV E6</scp>/<scp>E7 mRNA</scp> assay as primary screening test: Results from the <scp>NTCC2</scp> trial
International Journal of Cancer 2022cited by 47position: firstdoi
Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study
Clinical Gastroenterology and Hepatology 2022cited by 31position: middledoi
How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study
British Journal of Cancer 2022cited by 24position: middledoi
A deep learning approach for Spatio-Temporal forecasting of new cases and new hospital admissions of COVID-19 spread in Reggio Emilia, Northern Italy
Journal of Biomedical Informatics 2022cited by 22position: middledoi
Thyroidectomies in Italy: A Population-Based National Analysis from 2001 to 2018
Thyroid 2022cited by 17position: middledoi
Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme
Cancers 2022cited by 4position: middledoi
Colon cancer survival differs from right side to left side and lymph node harvest number matter
BMC Public Health 2021cited by 61position: lastdoi
Trends in thyroid function testing, neck ultrasound, thyroid fine needle aspiration, and thyroidectomies in North-eastern Italy
Journal of Endocrinological Investigation 2021cited by 27position: middledoi
GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature
Diagnostics 2021cited by 24position: middledoi
Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study
Digestive and Liver Disease 2021cited by 6position: middledoi
Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68–69
European Radiology 2021cited by 2position: middledoi
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
Nature Reviews Clinical Oncology 2020cited by 431position: middledoi
Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal Cancer
Clinical Gastroenterology and Hepatology 2020cited by 27position: middledoi
Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study
BJOG An International Journal of Obstetrics & Gynaecology 2020cited by 18position: middledoi
Physical Distancing, Face Masks, and Eye Protection to Prevent Person-Person COVID-19 Transmission: A Systematic Review and Meta-Analysis
SSRN Electronic Journal 2020cited by 13position: middledoi
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study
Breast Cancer Research and Treatment 2020cited by 3position: middledoi
Breast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines
Annals of Internal Medicine 2019cited by 287position: middledoi
Annual mammography at age 45–49 years and biennial mammography at age 50–69 years: comparing performance measures in an organised screening setting
European Radiology 2019cited by 12position: middledoi
Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme
Journal of Medical Screening 2019cited by 3position: middledoi
Cancer incidence following long-term consumption of drinking water with high inorganic selenium content
The Science of The Total Environment 2018cited by 57position: lastdoi
Cohort profile: the Italian Network of Longitudinal Metropolitan Studies (IN-LiMeS), a multicentre cohort for socioeconomic inequalities in health monitoring
BMJ Open 2018cited by 24position: middledoi
Prevalence and Determinants of Oral Human Papillomavirus Infection in 500 Young Adults from Italy
PLoS ONE 2017cited by 46position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Fabio Falcini · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori7 papers (2015–2022)Stefano Ferretti · Regione del Veneto7 papers (2015–2022)Guglielmo Ronco · London School of Hygiene & Tropical Medicine5 papers (2013–2022) · 4 papers (2019–2022) · 4 papers (2019–2022)Orietta Giuliani · Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori4 papers (2019–2022) · 4 papers (2019–2022)Priscilla Sassoli de Bianchi · University of Ferrara4 papers (2019–2022) · 4 papers (2019–2022) · 4 papers (2019–2022)Lauro Bucchi · University of Ferrara4 papers (2019–2022)Alessandra Ravaioli · University of Ferrara4 papers (2019–2022) · 4 papers (2019–2022)Chris J.L.M. Meijer · Dutch Cancer Society3 papers (2013–2014)Nereo Segnan · Azienda Ospedaliera Citta' della Salute e della Scienza di Torino3 papers (2013–2014) · 3 papers (2021–2022)Henry C Kitchener · University of Manchester3 papers (2013–2014)Joakim Dillner · Regional Cancer Center3 papers (2013–2014)Julian Peto · London School of Hygiene & Tropical Medicine3 papers (2013–2014) · 3 papers (2018–2022)